Posts about

Syndicated Studies

What does MM mean to me? A special interview with DR. Christine MAÏ - APLUSA

AplusA News, Healthcare Industry, Syndicated Studies, hematology, MMActionMonth, Multiple Myeloma

Myeloma Action Month is held every year for the whole month of March to encourage individuals and...

Post ASH 23 webinar with Dr. Blin | Focus on MM session

AplusA News, hemato-oncology, Syndicated Studies, ASH, hematology, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...

💉 APLUSA Vaccine Expertise presented by William MacGILLIVRAY

Syndicated Studies, vaccine

AplusA ensures you are up-to-date with the latest vaccine market developments.

Over 30 years,...

CMV: current management and opportunities for future treatments for Cytomegalovirus

hemato-oncology, Syndicated Studies, CMV, Infectiology

New in 2023 !

MDS: Treatment paradigms are changing

hemato-oncology, Tracking Studies, Syndicated Studies, Oncology

MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment...

Our brand new 2020 Syndicated Surveys

COVID-19, Syndicated Studies

Our range of syndicated studies now covers over 30 indications, many of them with results already...

COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study

COVID-19, Syndicated Studies

How does COVID-19 affectthe HCPS relationships with patients and with the pharmaceutical industry?...

mRCC: promising new combinations lead to disruption in L1 and L2

Syndicated Studies, Oncology

Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...

COVID-19 road to recovery: 5 key insights from our syndicated study

COVID-19, Syndicated Studies

As the global number of infected cases surpasses 46 million (Nov 2, 2020), there is a non-stop...

DLBCL Patient Insights in the US and EU5

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies

When working on a new or existing brand within the DLBCL market it's important to have up to date...